Cargando…

Towards a Device Agnostic AI for Diabetic Retinopathy Screening: An External Validation Study

PURPOSE: To evaluate the performance of a validated Artificial Intelligence (AI) algorithm developed for a smartphone-based camera on images captured using a standard desktop fundus camera to screen for diabetic retinopathy (DR). PARTICIPANTS: Subjects with established diabetes mellitus. METHODS: Im...

Descripción completa

Detalles Bibliográficos
Autores principales: Rao, Divya Parthasarathy, Sindal, Manavi D, Sengupta, Sabyasachi, Baskaran, Prabu, Venkatesh, Rengaraj, Sivaraman, Anand, Savoy, Florian M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393096/
https://www.ncbi.nlm.nih.gov/pubmed/36003071
http://dx.doi.org/10.2147/OPTH.S369675
_version_ 1784771195470610432
author Rao, Divya Parthasarathy
Sindal, Manavi D
Sengupta, Sabyasachi
Baskaran, Prabu
Venkatesh, Rengaraj
Sivaraman, Anand
Savoy, Florian M
author_facet Rao, Divya Parthasarathy
Sindal, Manavi D
Sengupta, Sabyasachi
Baskaran, Prabu
Venkatesh, Rengaraj
Sivaraman, Anand
Savoy, Florian M
author_sort Rao, Divya Parthasarathy
collection PubMed
description PURPOSE: To evaluate the performance of a validated Artificial Intelligence (AI) algorithm developed for a smartphone-based camera on images captured using a standard desktop fundus camera to screen for diabetic retinopathy (DR). PARTICIPANTS: Subjects with established diabetes mellitus. METHODS: Images captured on a desktop fundus camera (Topcon TRC-50DX, Japan) for a previous study with 135 consecutive patients (233 eyes) with established diabetes mellitus, with or without DR were analysed by the AI algorithm. The performance of the AI algorithm to detect any DR, referable DR (RDR Ie, worse than mild non proliferative diabetic retinopathy (NPDR) and/or diabetic macular edema (DME)) and sight-threatening DR (STDR Ie, severe NPDR or worse and/or DME) were assessed based on comparisons against both image-based consensus grades by two fellowship trained vitreo-retina specialists and clinical examination. RESULTS: The sensitivity was 98.3% (95% CI 96%, 100%) and the specificity 83.7% (95% CI 73%, 94%) for RDR against image grading. The specificity for RDR decreased to 65.2% (95% CI 53.7%, 76.6%) and the sensitivity marginally increased to 100% (95% CI 100%, 100%) when compared against clinical examination. The sensitivity for detection of any DR when compared against image-based consensus grading and clinical exam were both 97.6% (95% CI 95%, 100%). The specificity for any DR detection was 90.9% (95% CI 82.3%, 99.4%) as compared against image grading and 88.9% (95% CI 79.7%, 98.1%) on clinical exam. The sensitivity for STDR was 99.0% (95% CI 96%, 100%) against image grading and 100% (95% CI 100%, 100%) as compared against clinical exam. CONCLUSION: The AI algorithm could screen for RDR and any DR with robust performance on images captured on a desktop fundus camera when compared to image grading, despite being previously optimized for a smartphone-based camera.
format Online
Article
Text
id pubmed-9393096
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-93930962022-08-23 Towards a Device Agnostic AI for Diabetic Retinopathy Screening: An External Validation Study Rao, Divya Parthasarathy Sindal, Manavi D Sengupta, Sabyasachi Baskaran, Prabu Venkatesh, Rengaraj Sivaraman, Anand Savoy, Florian M Clin Ophthalmol Original Research PURPOSE: To evaluate the performance of a validated Artificial Intelligence (AI) algorithm developed for a smartphone-based camera on images captured using a standard desktop fundus camera to screen for diabetic retinopathy (DR). PARTICIPANTS: Subjects with established diabetes mellitus. METHODS: Images captured on a desktop fundus camera (Topcon TRC-50DX, Japan) for a previous study with 135 consecutive patients (233 eyes) with established diabetes mellitus, with or without DR were analysed by the AI algorithm. The performance of the AI algorithm to detect any DR, referable DR (RDR Ie, worse than mild non proliferative diabetic retinopathy (NPDR) and/or diabetic macular edema (DME)) and sight-threatening DR (STDR Ie, severe NPDR or worse and/or DME) were assessed based on comparisons against both image-based consensus grades by two fellowship trained vitreo-retina specialists and clinical examination. RESULTS: The sensitivity was 98.3% (95% CI 96%, 100%) and the specificity 83.7% (95% CI 73%, 94%) for RDR against image grading. The specificity for RDR decreased to 65.2% (95% CI 53.7%, 76.6%) and the sensitivity marginally increased to 100% (95% CI 100%, 100%) when compared against clinical examination. The sensitivity for detection of any DR when compared against image-based consensus grading and clinical exam were both 97.6% (95% CI 95%, 100%). The specificity for any DR detection was 90.9% (95% CI 82.3%, 99.4%) as compared against image grading and 88.9% (95% CI 79.7%, 98.1%) on clinical exam. The sensitivity for STDR was 99.0% (95% CI 96%, 100%) against image grading and 100% (95% CI 100%, 100%) as compared against clinical exam. CONCLUSION: The AI algorithm could screen for RDR and any DR with robust performance on images captured on a desktop fundus camera when compared to image grading, despite being previously optimized for a smartphone-based camera. Dove 2022-08-17 /pmc/articles/PMC9393096/ /pubmed/36003071 http://dx.doi.org/10.2147/OPTH.S369675 Text en © 2022 Rao et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Rao, Divya Parthasarathy
Sindal, Manavi D
Sengupta, Sabyasachi
Baskaran, Prabu
Venkatesh, Rengaraj
Sivaraman, Anand
Savoy, Florian M
Towards a Device Agnostic AI for Diabetic Retinopathy Screening: An External Validation Study
title Towards a Device Agnostic AI for Diabetic Retinopathy Screening: An External Validation Study
title_full Towards a Device Agnostic AI for Diabetic Retinopathy Screening: An External Validation Study
title_fullStr Towards a Device Agnostic AI for Diabetic Retinopathy Screening: An External Validation Study
title_full_unstemmed Towards a Device Agnostic AI for Diabetic Retinopathy Screening: An External Validation Study
title_short Towards a Device Agnostic AI for Diabetic Retinopathy Screening: An External Validation Study
title_sort towards a device agnostic ai for diabetic retinopathy screening: an external validation study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393096/
https://www.ncbi.nlm.nih.gov/pubmed/36003071
http://dx.doi.org/10.2147/OPTH.S369675
work_keys_str_mv AT raodivyaparthasarathy towardsadeviceagnosticaifordiabeticretinopathyscreeninganexternalvalidationstudy
AT sindalmanavid towardsadeviceagnosticaifordiabeticretinopathyscreeninganexternalvalidationstudy
AT senguptasabyasachi towardsadeviceagnosticaifordiabeticretinopathyscreeninganexternalvalidationstudy
AT baskaranprabu towardsadeviceagnosticaifordiabeticretinopathyscreeninganexternalvalidationstudy
AT venkateshrengaraj towardsadeviceagnosticaifordiabeticretinopathyscreeninganexternalvalidationstudy
AT sivaramananand towardsadeviceagnosticaifordiabeticretinopathyscreeninganexternalvalidationstudy
AT savoyflorianm towardsadeviceagnosticaifordiabeticretinopathyscreeninganexternalvalidationstudy